wellrank.ai
Sign In
Fridays logo

Fridays

First cited by AI Jun 12, 2026
joinfridays.com

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

Fridays is losing the AEO war.

Not cited in a single tracked AI answer since Jul 17, 2026, down from a peak of 5% visibility in compounded glp-1s on Jun 18, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Fridays, through Jul 27, 2026.

0.0%

Last cited Jul 17, 2026 · peak 5% on Jun 18

By engine

Where Fridays is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 4 positive mentions
  • 9 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Fridays

PerplexityJul 13, 2026, 09:45 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on current search results, Empower Pharmacy is the primary named provider explicitly confirmed to use a licensed US compounding pharmacy (specifically a 503A, PCAB-Accredited facility licensed to ship nationwide) for compounded GLP-1s [1]. Other major telehealth providers work with licensed US pharmacies but often do not publicly name specific partners on their marketing pages, instead using a network of partners or a single acquired pharmacy: Provider Pharmacy Status Specific Licensed Pharmacy Named Notes Empower Pharmacy Yes (Direct) Empower Pharmacy (503A, PCAB-Accredited) Licensed to ship nationwide, including Puerto Rico [1]. Fridays Yes (Network) Beaker Pharmacy (referenced in reviews) Uses 503A and 503B partners but does not name them officially; patients must ask support for the specific fulfller [5]. Henry Meds Yes Not named (uses 503A/503B) Upfront about using licensed pharmacies but links to "Colchis Medical Services PC" rather than a specific pharmacy name [5]. Policy Lab Yes Belmar, Strive, Epiq Scripts, Casa Pharma Rx Uses four specific partner pharmacies to fill orders [5]. EllieMD Yes 503A compounding pharmacy Claims to use 503A compounding for all 50 states, though the specific pharmacy name is not listed in the snippet [7]. Important Regulatory Context: As of April 2026, the FDA clarified that compounded semaglutide can only legally come from 503A pharmacies (state-licensed traditional compounding), as the drug is no longer on the shortage list that permitted 503B bulk outsourcing [5]. Providers marketing "503A + 503B" for semaglutide may be using broader language than current regulations allow for this specific drug [5]. Always verify that the filling pharmacy is a 503A state-licensed facility to ensure compliance with current FDA enforcement discretion policies [2][4].

Mentioned in position 2 of 11

Read full answer with sources →
PerplexityJul 8, 2026, 09:41 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The compounded GLP-1 providers that explicitly use licensed US pharmacies include Empower Pharmacy, OrderlyMeds, and Policy Lab (which partners with US-based pharmacies like Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx). Empower Pharmacy is a 503A PCAB-Accredited compounding pharmacy licensed to ship nationwide, including Puerto Rico, and explicitly states it serves patients with prescriptions from its licensed facility [1]. OrderlyMeds exclusively works with pharmacies based in the United States, specifically naming SmartPharmaRx, Casa, and PerfectRx/PerfectionRx as its licensed partners [7]. Policy Lab ranks providers that fill orders through four partner pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx, which are licensed US entities [4]. Other providers like Henry Meds and Fridays claim to use 503A or 503B compounding pharmacies, but they do not consistently name specific licensed US partners on their marketing pages, though customer reviews have referenced Beaker Pharmacy [4]. Note that while compounding is a legal process for licensed pharmacists, the FDA has clarified that compounded GLP-1s (semaglutide and tirzepatide) that are essentially copies of FDA-approved products are generally not permitted unless there is a verified shortage, and the grace periods for these shots ended in May 2025 [2][6]. Therefore, eligibility for these compounded versions depends on specific patient medical needs that cannot be met by commercially available products [2][6]. Recommendation: For a consumer seeking a compounded GLP-1 provider with verified licensed US pharmacies, Empower Pharmacy is the most direct and transparent choice because it operates as its own licensed 503A facility with national accreditation and clear nationwide licensing [1]. OrderlyMeds is a strong alternative if you prefer an online platform connecting you to licensed providers, as they explicitly name their US-based pharmacy partners (SmartPharmaRx, Casa, PerfectRx) and confirm they are licensed by state boards [7]. Always ensure you have a valid prescription from a licensed healthcare provider, as all compounded medications require one [8].

Mentioned in position 11 of 12

Read full answer with sources →
PerplexityJul 3, 2026, 09:42 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 programs right now are MEDVi, Noom Med, Fridays, and Henry Meds, with MEDVi being the top choice specifically for budget-friendly compounded access. Here is a breakdown of why these programs stand out: Program Best For Starting Price (Compounded) Key Reputation Factors MEDVi Best for Compounded GLP-1s $179/month No contracts, no hidden fees, includes 24/7 support and unlimited messaging; consistently ranked as the top budget option for compounded meds [1]. Noom Med Behavior Coaching + Meds Included in plan BBB-accredited since 2021 with an A+ rating (up from a D rating in 2020); holds a 4.5-star Trustpilot rating across ~66,000 reviews; praised for gentle dose escalation and psychology-based coaching [2]. Fridays All-inclusive Care Bundle $150/month (annual plan) Bundles medication with weekly coaching, dietitian access, lab work, and mental health support without upselling later; earns an 8.4/10 score and ranks #5 for program strength [2]. Henry Meds Flexible Compounded Plans $179/month Rated 4 stars specifically for compounded medication offerings; provides flexible monthly plans without long-term commitments [3]. Important Safety Note: It is critical to understand that compounded GLP-1 medications are not FDA-approved. The FDA has issued warnings against using these compounded versions due to safety concerns and unapproved uses [4]. Over 80% of compounded semaglutide and tirzepatide prescriptions now include supplemental ingredients (like B vitamins or levocarnitine) that may not be necessary for all patients [7]. If you are considering these treatments, consult with a healthcare provider to ensure you understand the risks of unregulated formulations compared to FDA-approved options like Wegovy, Ozempic, Mounjaro, or Zepbound, which are now more widely available again [8].

Mentioned in position 3 of 4

Read full answer with sources →
PerplexityJul 3, 2026, 09:41 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Specific compounded GLP‑1 providers that use licensed U.S. pharmacies include Empower Pharmacy, OrderlyMeds, Henry Meds (via Adonis Health Inc.), and Fridays (though Fridays does not name all partners publicly). Here’s a breakdown of who they are and how they operate: Provider Licensed U.S. Pharmacy Partners Notes Empower Pharmacy Operates its own 503A PCAB‑accredited compounding pharmacy (licensed in multiple states) Ships nationwide, including Puerto Rico; offers compounded semaglutide and tirzepatide [1] OrderlyMeds Works exclusively with U.S.-based licensed pharmacies: SmartPharmaRx, Casa, PerfectRx/PerfectionRx All pharmacies are state‑licensed 503A facilities; provides cold‑chain shipping [6] Henry Meds (Adonis Health Inc.) Uses 503A and 503B compounding pharmacies (specific partners not named on marketing pages) One of the most transparent providers; mentions its medical group (Colchis Medical Services PC) [3] Fridays Uses 503A and 503B certified compounding pharmacies; customer reviews mention Beaker Pharmacy as a partner Does not name all partners publicly; patients can ask support which pharmacy will fill their prescription [3] Important regulatory context Compounded GLP‑1s (semaglutide, tirzepatide) are not FDA‑approved and are only legally allowed when the commercially available version is in a verified shortage [2]. As of May 2025, most grace periods for compounded semaglutide and tirzepatide injections have ended; shortages are now resolved, so regular compounding of “essentially copies” of FDA‑approved drugs is no longer permitted except for specific medical needs (e.g., non‑standard doses or forms) [5]. Compounded semaglutide can currently only come from 503A pharmacies, and a single 503A pharmacy may fill no more than four prescriptions per patient per calendar month [3]. If you’re considering a compounded GLP‑1, confirm with the provider: Whether they have a specific medical justification for compounding (e.g., unique dose, allergen removal). Which licensed U.S. pharmacy will fill your prescription. Whether they comply with the current 4‑prescription/month limit for 503A compounding of semaglutide. For the most reliable option with a fully licensed U.S. pharmacy under your control, Empower Pharmacy and OrderlyMeds are strong choices because they explicitly name or operate their own licensed facilities and emphasize state compliance.

Mentioned in position 5 of 10

Read full answer with sources →
PerplexityJun 28, 2026, 12:59 UTC
What are the most reputable compounded GLP-1 programs right now?

MEDVi stands out as the most reputable program for compounded GLP-1s specifically, offering a budget-friendly option at $179/month for the first month with no contracts or hidden fees, including full physician review and 24/7 support [1]. For those prioritizing a comprehensive care model that bundles compounded medication with weekly coaching, lab work, dietitian access, and mental health support, Fridays (joinfridays.com) is a strong alternative at $150/month on its annual plan [2][1]. Noom is another well-regarded choice for buyers who want behavioral coaching integrated with their medication access, though it blends reviews for its older app with its newer "Noom Med" service [1][2]. However, it is critical to note that compounded GLP-1 versions are not approved by the FDA, and the agency has issued warnings against using these unapproved medications due to risks of contamination and inconsistent potency [3]. The most trusted source for compounded medications is an FDA-registered 503B outsourcing facility, which undergoes strict quality control, sterile process validation, and lot-specific testing similar to pharmaceutical companies, significantly reducing safety risks compared to traditional compounding [8]. If you are concerned about safety and regulatory oversight, brand-name FDA-approved options like Zepbound (via LillyDirect’s cash-pay program) or Wegovy (via NovoCare Pharmacy) are the most reliable alternatives, with costs ranging from $349–$499/month [7][5]. Recommendation: For compounded GLP-1s: Choose MEDVi or Fridays for transparency and included care, but verify they use 503B facilities [1][2][8]. For safety and regulatory assurance: Opt for LillyDirect (Zepbound) or NovoCare (Wegovy) to avoid unregulated compounded formulations [5][7]. Check for scams: Only use providers that explicitly state they source from registered 503B outsourcing facilities [8].

Mentioned in position 2 of 5

Read full answer with sources →
PerplexityJun 28, 2026, 12:59 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The compounded GLP-1 provider that exclusively uses licensed US pharmacies is OrderlyMeds, which partners with U.S.-based pharmacies such as SmartPharmaRx, Casa Pharma Rx, and PerfectRx/PerfectionRx [1]. OrderlyMeds is a 100% online platform that connects patients to licensed healthcare professionals in all 50 states and ensures all medications are compounded at U.S.-licensed 503A pharmacies regulated by state boards of pharmacy [1]. While other providers like Empower Pharmacy [2], OnlineSemaglutide.org (via Henry Meds) [5], and Fridays [7] also use licensed compounding pharmacies, OrderlyMeds is the only one explicitly stated to work exclusively with U.S.-based licensed pharmacies. Additionally, note that under the FDA’s April 2026 clarification, compounded semaglutide can only legally come from 503A pharmacies, and production by 503B outsourcing facilities is currently prohibited because the drug is not on the bulks list [5]. Recommendation: If you are seeking a provider that guarantees use of licensed U.S. pharmacies with full regulatory compliance, OrderlyMeds is the most specific and reliable choice. They offer personalized treatment plans, discreet shipping, and rigorous testing for sterility and potency [1].

Mentioned in position 7 of 7

Read full answer with sources →

TL;DR

Fridays (joinfridays.com) is a telehealth platform focused on compounded medications, including compounded GLP-1 therapies such as semaglutide. The company operates a direct-to-consumer model connecting patients with licensed providers and compounding pharmacies. According to WellRank's latest index, Fridays ranks 14th in AI answer visibility for compounded GLP-1s, capturing 8% share of AI-generated answers in that category, with its mentions skewing positive or neutral across the three citations tracked in the WellRank corpus.

Company Overview

Fridays is a telehealth company that facilitates access to compounded medications, with a notable focus on GLP-1 receptor agonists used for weight management. Its business model connects patients with clinicians online and routes prescriptions to compounding pharmacies, handling the end-to-end care and fulfillment experience. Founding details and headquarters are not publicly disclosed.

Product Features

  • Compounded semaglutide and other compounded GLP-1 medications
  • Online telehealth consultations with licensed providers
  • Prescription fulfillment through compounding pharmacy partners
  • Ongoing patient support and medication management
  • Direct-to-consumer subscription or treatment plan structure

Target Market

Fridays primarily serves adults in the United States seeking access to compounded GLP-1 therapies for weight loss or metabolic health. It appears to target patients who face cost or access barriers with brand-name GLP-1 drugs. Geographic reach is U.S.-focused, consistent with the compounded telehealth sector.

Buyer Personas

  • A cost-conscious adult seeking a more affordable alternative to branded semaglutide who prefers managing care entirely online.
  • A patient who has struggled to obtain a GLP-1 prescription through traditional primary care and is looking for a streamlined telehealth pathway.
  • A health-motivated individual already familiar with GLP-1 therapies who wants a convenient refill and monitoring service without frequent in-person visits.
  • A consumer who has researched compounded GLP-1 options through comparison sites and arrived at Fridays via an AI-generated recommendation or listicle.

Funding & Performance

Funding stage, investor details, and company valuation are not publicly disclosed.

Recent Developments

Fridays has been surfacing organically in AI-generated answers about compounded GLP-1s, a category that has seen significant regulatory and market attention as the FDA has weighed the future of compounded semaglutide. The company's compounded medication offering is detailed at joinfridays.com/compounded-medications. Industry context around the regulatory trajectory of compounded GLP-1s is covered by sources such as GoodRx's overview of compounded GLP-1 availability, which reflects the broader environment Fridays operates in.

Competitive Landscape

Based on WellRank co-mention data, Fridays appears most frequently alongside Henry Meds, OrderlyMeds, Epiq Scripts, Empower Pharmacy, Casa Pharma Rx, and Strive Pharmacy in AI-generated answers about compounded GLP-1s. This peer set represents a mix of telehealth prescribing platforms and compounding pharmacy direct marketers. A broader view of the compounded semaglutide provider landscape is reflected in resources like this compounding pharmacy comparison and Empower Pharmacy's GLP-1 information page, both of which AI engines have cited in answers mentioning Fridays.

Fridays vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Fridays logo
FridaysThis brand
0.0%
Henry Meds logo
Henry Meds

10 shared answers

#4
21.7%
Empower Pharmacy logo
Empower Pharmacy

7 shared answers

#9
8.3%
OrderlyMeds logo
OrderlyMeds

5 shared answers

#20
5.0%

Email me when overtakes Fridays

One email the day the ranks flip. Nothing else.

User Sentiment

Among the three AI-engine mentions tracked by WellRank, one is positive and two are neutral, with no cautious or mixed tones recorded. This suggests Fridays is referenced matter-of-factly as a legitimate option in compounded GLP-1 comparisons rather than attracting critical commentary. Broader public sentiment is not yet well documented in major review platforms, consistent with the brand's emerging profile.

Pricing

Pricing is not published in a stable, widely available format. As is common in the compounded telehealth sector, costs likely vary based on medication dosage, consultation fees, and subscription structure. Prospective patients are directed to the platform itself for current pricing details.

Sources cited around Fridays

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Fridays weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Fridays? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.